The fastest route to a correct antibody concentration is a short, assay-specific serial titration, with the working concentration reported in μg/ml or ng/test rather than as a dilution factor alone. This antibody dilution guide covers western blot, IHC/ICC, immunofluorescence, flow cytometry and ELISA, and sets out the reproducibility habits that matter most: retitrating every new lot and recording catalogue and lot numbers alongside the final concentration.
TL;DR:
- Conduct assay-specific titrations to determine accurate antibody working concentrations in μg/ml, rather than relying solely on vendor recommended dilutions.
- Prepare serial dilutions using calibrated pipettes, and record the exact mass concentration, buffer composition, and incubation details to ensure reproducibility.
- Optimize antibody concentration by plotting signal-to-noise ratios and selecting a concentration near 90% of saturation on the response curve.
- Adjust titration ranges depending on the method: two-log dilutions for IHC/ICC, 8-12 two-fold points for flow cytometry, and protein mass calculations for ELISA.
- Always mini-titrate new antibody lots and document lot, catalog number, and concentration data to prevent lot-to-lot variability issues.
Table of Contents
- Quick reference: starting dilution ranges and conversions
- Step-by-step titration protocol
- Calculations and using dilution calculators safely
- Assay-specific adjustments across common methods
- Troubleshooting concentration-related failure modes
- Minimal reporting checklist for reproducibility
- How ABMIUM supports validated antibody sourcing
- A practical checklist and a short note on vendor dilutions
- Finding validated antibodies and support through ABMIUM
- FAQ
- Sources
Quick reference: starting dilution ranges and conversions
Vendor datasheets give a starting point, never a guarantee. A titration experiment is the practical way to find the optimal working concentration, and the concentration should be reported in μg/ml wherever that figure is available, according to a peer-reviewed western blot validation protocol. That protocol includes a consensus table of starting estimates across assays and stock preparations, which we summarise below as a scanning reference, not as a fixed rule.
These ranges come from the same consensus table and are deliberately wide: the right concentration for any individual antibody and sample still has to be found by titration.
Two conversions come up constantly at the bench. To prepare a 1:1,000 dilution, take 1 part antibody stock and add 999 parts diluent, so 1 µL of stock into 999 µL of buffer gives 1 mL of working solution at 1:1,000. To prepare 1 μg/ml from a 2 mg/ml stock, first convert units: 2 mg/ml equals 2,000 μg/ml. The dilution factor needed is the stock concentration divided by target concentration, so a 1:2,000 dilution of that stock gives 1 μg/ml. For 1 mL of final working solution, that means mixing proportionally.
Starting ranges exist to save time, not to replace titration. The Human Protein Atlas makes the point plainly: validation is application-specific, and an antibody that performs well in western blot may behave differently in IHC or flow because of differences in antigen conformation and accessibility across sample types. Treat every number in the table above as a sensible place to start a titration, never as the answer itself.
Step-by-step titration protocol
A titration is not a luxury step reserved for difficult antibodies. It is the only reliable way to find the concentration that gives maximum signal with minimum background for a specific antibody, lot and sample type, and it should be run before an antibody is trusted for a new application.
Materials and plate format. Use a 96-well plate for serial dilutions regardless of the final assay, since it keeps the dilution series organised and easy to pipette from. For flow cytometry, final staining volumes of 200 to 300 µL per test are standard, which keeps cell concentration and antibody concentration consistent across the panel, following the protocol detail in a flow cytometry titration review. For western blot, calculate incubation volume from membrane surface area rather than a fixed figure, since a mini-gel membrane needs far less antibody solution than a full-size transfer.
Choosing the dilution series. An 8 to 12 point, two-fold serial dilution is the standard range for flow cytometry titration, broad enough to capture the full concentration-response curve without an impractical number of points, as set out in the same flow cytometry review. For IHC and quantitative immunofluorescence, the series often needs to span at least two full logs of concentration, for example 1:100 to 1:10,000 or 0.01 to 10 μg/ml, to capture the full dynamic range on serial sections or tissue microarrays, according to a protocol for antibody validation in tissue immunohistochemistry.
- Calculate the starting concentration from the stock’s labelled concentration, using the higher end of the relevant assay range from the table above.
- Prepare the first well at that concentration, then perform a two-fold serial dilution across the remaining wells using the same diluent used in the final assay.
- Run the full dilution series alongside a positive control sample and a secondary-only (no primary antibody) control.
- Process the assay exactly as it will be run routinely: same incubation time, same temperature, same wash steps.
- Record the raw signal and background at every dilution point, then calculate signal-to-noise or stain index for each.
- Plot concentration against signal-to-noise and identify the plateau, not the single highest point.
- Select a working concentration at approximately 90% of the saturating signal, which typically sits just before the curve flattens.
- Repeat the titration on a second sample type if the antibody will be used across more than one assay or tissue.
Defining the optimal concentration. The stain index, or separation index in multicolour panels, is a practical, quantifiable way to pick a titer that balances brightness against background, and the useful concentration usually sits on a plateau region of the curve rather than at its absolute peak, per the flow cytometry titration review. The same logic applies to IHC and IF: plotting signal-to-noise against concentration reveals a curve whose maximum marks the optimal working concentration, and one tissue validation protocol reports a case where the optimal concentration peaked at 0.5 μg/ml despite a much higher concentration being available on the datasheet, according to the IHC validation protocol.
Pipetting accuracy and waste. Serial dilutions compound small pipetting errors at every step, so use calibrated pipettes appropriate to each volume rather than one pipette across a wide range, and mix each dilution thoroughly before drawing the next aliquot.
Pro Tip: Prepare only the volume of each dilution you need for that day’s titration plate, and keep the remaining stock as small frozen aliquots rather than one larger working stock, which limits freeze-thaw cycles and wasted antibody on a titration that may need repeating.
Calculations and using dilution calculators safely
Most dilution errors come from unit mismatches, not arithmetic mistakes, so it helps to work through the calculation by hand before trusting a calculator.
Worked example 1: making 1:1,000 from stock. A dilution factor of 1:1,000 means 1 part stock diluted into a total of 1,000 parts. For 1 mL of final volume, that is 1 µL of antibody stock added to 999 µL of diluent. The C1V1 = C2V2 relationship confirms this: if the stock concentration is C1 and the final concentration is C1 divided by 1,000, then V1 (the volume of stock needed) equals total volume divided by 1,000.
Worked example 2: converting mg/ml to a dilution factor. Say a certificate of analysis lists a stock concentration of 1 mg/ml and the target working concentration for ELISA is 2 μg/ml. Convert the stock to the same unit: 1 mg/ml equals 1,000 μg/ml. Divide stock by target: 1,000 divided by 2 equals 500, so the required dilution is 1:500. For 10 mL of final working solution, that is 20 µL of stock plus 9,980 µL of diluent.
A short checklist avoids the mistakes that cause most of the trouble:
- Check whether a datasheet dilution is written as a ratio (1:500) or a reciprocal fraction, since the two are easy to transpose under time pressure.
- Confirm whether a flow cytometry recommendation is given in µL per test or in ng per test. These are not interchangeable without knowing the stock concentration.
- Double-check mg/ml versus µg/ml before converting. A factor-of-1,000 error here is the single most common source of a failed titration.
- Verify the final volume a protocol assumes (per well, per membrane, per test) before scaling a calculation up or down.
When using an online dilution calculator, check three things before trusting the output: which units it expects for stock and target concentration, what final volume it assumes, and whether its result is a concentration or a dilution factor. A calculator that silently assumes mg/ml when you have entered µg/ml will return a result that is off by three orders of magnitude.
Assay-specific adjustments across common methods
Starting ranges and titration logic change meaningfully by assay, and a protocol tuned for one technique rarely transfers cleanly to another.
- Western blot: scale primary antibody incubation volume to membrane surface area rather than a fixed figure, since mini-gel membranes need proportionally less solution than full-size blots, and note that blocking buffer composition (milk versus BSA) can shift the effective working dilution for antibodies sensitive to blocking agent.
- IHC and ICC: antigen retrieval conditions change effective epitope availability, so a titration run after one retrieval method does not guarantee the same result after another, and dilution ranges for these assays often span two full logs of concentration rather than a narrow band, per the IHC/ICC validation protocol. Long overnight incubations at 4°C are common and often improve signal-to-noise compared with shorter room-temperature incubations. Amplification systems such as polymer-HRP with DAB (amplification systems such as polymer-HRP with DAB) or tyramine signal amplification, increase sensitivity but also amplify background, so a titration should be repeated whenever an amplification step is added or changed.
- Immunofluorescence: similar two-log dilution ranges apply, and quantitative IF benefits from the same signal-to-noise plotting approach used for IHC, choosing the concentration that maximises contrast rather than raw brightness.
- Flow cytometry: many vendors supply concentration as µL per test, which converts to a recommended starting point around 1,000 ng/test for antibodies supplied in mg/ml, with titration run across 8 to 12 two-fold dilution points in a 96-well plate and read out using the stain index, following guidance from the flow cytometry titration review. Multicolour panels add complexity, since spillover from neighbouring channels can shift the apparent optimal concentration for a given marker, which is why a separation index that accounts for spread is often preferred over a simple stain index in panels beyond four or five colours.
- ELISA: report concentration in µg/ml rather than dilution factor wherever possible, since plate-based assays are highly sensitive to absolute antibody mass per well, and purified antibodies typically start titration in the 1:1,000 to 1:10,000 range depending on target abundance.
- Immunoprecipitation: capture efficiency usually requires a higher absolute antibody mass than detection-based assays, since much of the antibody is spent on capturing a low-abundance target rather than generating signal, so IP protocols commonly use several micrograms of antibody per reaction rather than a simple dilution of a working stock.
Pro Tip: When a protocol calls for an amplification system, such as tyramine signal amplification, retitrate the primary antibody with the amplification step in place rather than reusing a concentration optimised for an unamplified detection method.
Troubleshooting concentration-related failure modes
When a result looks wrong, concentration is only one of several possible causes, and a short diagnostic sequence narrows it down faster than changing several variables at once.
- Check the positive control first. If the positive control fails, the problem is likely upstream of antibody concentration, such as sample preparation or detection chemistry.
- If the positive control works but the experimental sample does not, run one dilution step higher in concentration and one step lower in the same assay to see whether signal appears at either extreme.
- Run a secondary-only control (no primary antibody) alongside the titration to separate primary antibody background from secondary antibody or detection system background.
- Compare the observed signal against the certificate of analysis for that lot, since manufacturer-labelled concentrations can be preliminary estimates and the active antibody concentration may be lower than stated due to impurities or stabilisers, according to a widely cited antibody validation checklist.
- If background is high across the whole titration series rather than concentrated at the highest dilution, suspect the secondary antibody or detection system rather than the primary, and test a secondary antibody dilution series independently of the primary.
- If a previously working concentration suddenly fails, request a new certificate of analysis for the current lot and run a three-point mini-titration (recommended concentration, twice that, and half that) before assuming the protocol itself has changed.
Excess primary antibody and secondary-driven background look similar on a blot or slide but behave differently when diluted further: true excess primary antibody background drops as the primary is diluted, while secondary-driven background persists and needs a change in blocking buffer, secondary antibody concentration, or wash stringency instead. An example secondary antibody product page is a useful reference point for how secondary concentration is typically specified, since secondary antibody concentration has its own independent effect on both signal and background and often needs its own short titration separate from the primary.
Lot variation and contamination are easy to overlook because the protocol itself has not changed. A sudden shift in background or signal after switching to a new vial of the same catalogue number is the clearest signal to run a fresh mini-titration rather than assume the original titration still applies, and checking the certificate of analysis for stabilisers such as glycerol or sodium azide can explain shifts that otherwise look unexplained.
Minimal reporting checklist for reproducibility
Reporting a dilution factor alone discards the information another lab needs to repeat an experiment, because the same 1:1,000 dilution means something different for two stocks at different concentrations. Reporting the working concentration in mass units lets another lab reproduce the result regardless of how their own stock is formulated.
- Catalogue number, lot number, and RRID where one is available, since these identify the exact reagent used rather than just the product name.
- Working concentration in μg/ml or ng/test, alongside the dilution factor for convenience.
- Incubation time and temperature, since both materially affect optimal concentration.
- Buffer composition, including blocking agent and any detergent, since these change effective antibody availability.
- Secondary antibody concentration and detection method, reported with the same rigour as the primary.
The International Working Group for Antibody Validation recommends reporting catalogue and lot numbers and RRIDs as standard practice, alongside at least one of its five validation pillars supporting the claim that an antibody is validated for the specific application in question.
A few lab habits make this checklist easy to maintain day to day: run a short three-point mini-titration whenever a new lot arrives rather than assuming the previous lot’s concentration still applies, aliquot stock antibody on receipt to limit freeze-thaw cycles, avoid reusing diluted primary antibody solutions across multiple experiments, and record storage conditions alongside the concentration data. Mass units matter here specifically because they survive a lot change or even a switch to a different supplier’s preparation of the same clone, while a dilution factor alone does not.
How ABMIUM supports validated antibody sourcing
Vendor datasheets do not always state concentration in mass units, and application-specific validation evidence is often missing entirely, which is a gap addressed by scientist-led sourcing services where researchers submit their experimental requirements and receive help comparing antibodies against the validation evidence actually available for that application.
Our primary antibody catalogue can be filtered by target, application, species, host and clonality, so a search can be narrowed to antibodies with evidence specific to the assay in question rather than evidence from an unrelated application. For antibodies where published validation is thin, our product validation service and native mass spectrometry option provide an independent check on identity and concentration before an antibody becomes the basis of a larger study. We also offer custom antibody development for targets where no suitably validated option exists in the market.
A researcher typically reaches out when a datasheet lists only a dilution factor with no stated concentration, when the available validation evidence covers a different application from the one planned, or when a critical experiment needs independent confirmation before results go into a paper or a regulatory submission.
A practical checklist and a short note on vendor dilutions
The routine worth keeping is simple: plan a titration before trusting any new antibody, run an 8 to 12 point two-fold dilution series specific to the assay, report the working concentration in mass units alongside the dilution factor, and mini-titrate every new lot before relying on it for a full experiment.
Every recommended dilution on a datasheet, however confident it sounds, is a starting point drawn from the manufacturer’s own conditions, not a promise about performance in a different lab, sample type or detection system. Treating it that way from the outset saves more failed experiments than any other single habit in antibody work.
— Veron
Finding validated antibodies and support through ABMIUM
Once a titration confirms the concentration an antibody needs, the next question is usually whether that antibody has the right evidence behind it for the application in question. Our catalogue and consultative services exist for exactly that stage of the work.
- Browse our primary antibodies catalogue, filterable by target, application, species, host and clonality, with validation evidence shown where available.
- Submit an experimental requirement through ABMIUM MATCH and receive scientist-led help comparing suitable antibodies and their supporting evidence.
- Independent confirmation services are available when a candidate antibody needs validation before it anchors a study.
For labs working with peptide-based immunogens or antigen handling during validation work, a peptide reconstitution guide covers practical solvent and carryover considerations worth knowing before antigen preparation begins.
Where a suitably validated antibody does not exist off the shelf, our custom antibody, protein and ELISA development service, detailed on our custom product page, builds one to the application’s actual requirements rather than leaving a gap unfilled.
FAQ
How do I dilute antibodies correctly?
Run a short serial titration specific to the assay, typically 8 to 12 two-fold dilution points, and select the concentration that gives the best signal-to-noise rather than simply using the vendor’s suggested dilution. Report the result in μg/ml or ng/test alongside the dilution factor so the result is reproducible across labs and lots.
How do I calculate the dilution of an antibody?
Use the C1V1 = C2V2 relationship: convert stock and target concentrations to the same unit, divide stock concentration by target concentration to get the dilution factor, then calculate the stock volume needed for the final volume required. For example, a 1 mg/ml stock diluted to 2 μg/ml requires a 1:500 dilution.
How to make 1:1000 antibody dilution?
Add 1 part antibody stock to 999 parts diluent, so for 1 mL of final working solution, use 1 µL of stock and 999 µL of buffer. Mix thoroughly before use, and prepare only the volume needed for that day’s experiment.
What is a good primary antibody dilution for immunofluorescence?
Purified antibodies for immunofluorescence often start titration somewhere in the 1:100 to 1:1,000 range, but the useful range for IF and IHC together can span at least two full logs of concentration, according to a tissue immunohistochemistry validation protocol. The correct concentration still needs to be confirmed by titration on the actual sample type and detection method planned for the experiment.